The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study

BACKGROUND: TNF inhibiting drugs (TNFi) provide symptomatic relief for patients with ankylosing spondylitis (AS), but uncertainty remains about long-term benefits. We compared hospital admissions, emergency department (ED) presentations, and direct health care costs before and after the availability...

Descripción completa

Detalles Bibliográficos
Autores principales: Nossent, Johannes, Inderjeeth, Charles, Keen, Helen, Preen, David, Li, Ian, Kelty, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814256/
https://www.ncbi.nlm.nih.gov/pubmed/34762289
http://dx.doi.org/10.1007/s40744-021-00393-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814256/
https://www.ncbi.nlm.nih.gov/pubmed/34762289
http://dx.doi.org/10.1007/s40744-021-00393-x

Ejemplares similares